The pharmaceutical sector, projected to nearly double to about USD 130 billion by 2030, aims to leverage favorable policies, demographics, and digital expertise to position India as a key player in enhancing global health for everyone...
The growth of the pharmaceutical excipient market is driven by the rising use of advanced drug delivery systems, biologics, and drug formulations focused on patient needs. The market is projected to increase from US$ 972.9 million in 2024 to US$...
The expansion of the pharmaceutical processing seals market is influenced by multiple factors, such as the rising intricacy of drug production, strict regulatory standards, and developments in drug delivery systems. A primary factor is the...
The pharmaceutical sector in India ranks among the leading industries drawing investments. India's healthcare and pharmaceutical industries secured Rs 14,811 crore through initial public offerings (IPOs) in 2024, marking the highest amount since...
The secondary packaging market for biologics CDMO is undergoing considerable expansion owing to the rising incidence of chronic illnesses globally. As chronic diseases become more common, the necessity for novel therapies and precision medicine...
Supriya Lifescience's new plant is anticipated to improve production capabilities, aiding its expansion in the competitive pharmaceutical sector. Pharma shares experienced a 6 percent rise after the launch of a modern E-Production Block in...
The PLI scheme will enhance resilience against external shocks, strengthen drug security, and increase the ability to produce critical bulk drugs and higher-value products domestically. The three support schemes revealed by the government will...
Dharampal S Rawat, Senior Director – Cardiovascular, Terumo Aortic and Life Care Solutions in a recent interaction with Industry Outlook magazine shared his views on how advancements in grafts are addressing
The Indian Pharmaceutical Market experienced significant growth, reaching Rs 19,388 crore in November 2024. Strategic pricing played a crucial role in this increase, as several therapies saw price rises. Chronic therapy areas, especially cardiac...
In a workshop hosted by the Central Drugs Standard Control Organization (CDSCO) and FDCA in association with the Indian Drug Manufacturers Association (IDMA), Dr. Naresh Sharma, Deputy Drugs Controller (India), highlights the importance of vendor ...
, CDSCO.jpg)
